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Effects of mutations in the b2-adrenergic
receptor (b2AR) gene on intraocular
pressure (IOP), in response to acute dynamic
exercise, were investigated in 19 healthy
males (age 22.6 ± 2.8 years). Intraocular
pressures were measured pre- and post-
exercise. Weight, height, body mass index,
and maximal oxygen (VO2max) uptake were
recorded and subjects were genotyped 
for Arg16Gly, Gln27Glu and Thr164Ile
mutations of the b2AR gene. Post-exercise,
reductions in mean IOP values were found
in 16 subjects with the Gly16Gly and
Arg16Gly genotypes, but these values
remained low in the eight patients with 
the Gly16Gly genotype 3 h post-exercise,
whereas they returned to baseline within 1 h
in the eight subjects with the Arg16Gly
genotype. b2AR stimulation during exercise
could be an important regulator of IOP
response and determining b2AR poly-
morphisms may improve understanding of
pathogenesis and treatment selection in
ophthalmic diseases, e.g. glaucoma.
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Introduction
The impact of dynamic exercise conditioning
on intraocular pressure (IOP) is not fully
understood, although transient reductions in
IOP produced by acute dynamic exercise are
well documented.1,2 Some experimental and
clinical studies imply that combining
exercise conditioning with medical therapy
may decrease IOP in glaucoma patients.1 – 5
Numerous mechanisms of action have been
postulated to explain the IOP-drop
associated with acute, dynamic exercise,
including changes in episcleral venous
pressure, plasma lactate levels, blood pH,
plasma osmolarity and hormone levels.5 – 11
Activation of the sympathetic nervous
system during exercise has already been
shown to cause a seven-fold increase in
circulating catecholamines in plasma.12,13 β2-
adrenergic receptor (β2AR) sites have been
demonstrated in non-pigmented ciliary
epithelial cells, human trabecular meshwork
cells, and retinal vessels, and most of these
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receptor sites are of the β2AR type.
14 – 16
The β2ARs belong to the superfamily of 
G-protein-coupled receptors, with amino
terminus localized extracellularly, seven
transmembrane-spanning domains, and an
intracellular carboxyl-terminus.17 The coding
region of the β2AR was first investigated by
Kobilka et al.18 and is located on chromosome
5q31. Three polymorphic β2ARs have been
studied in some detail and display altered
receptor function in vitro.19 Wild-type 
β2ARs contain Arg16, Gln27, and Thr164.
Compared to their wild types, mutant 
β2ARs display different receptor–effector
interactions, namely Gly versus Arg at codon
16, Glu versus Gln at codon 27, and Ile versus
Thr at codon 164.20,21 All three poly-
morphisms appear to alter receptor function,
and the airways of individuals with these
receptors are likely to behave differently
when exposed to circulating catecholamines
or exogenous drugs.19 The Gly16 form of the
receptor down-regulates following exposure
to an agonist, to a much greater extent than
the Arg16 form, in both transfected cell
systems and in primary cultured human
airway smooth-muscle cells.22 The Glu27
form exhibits a protective effect against
down-regulation, in both transfected and
non-transfected cell systems.22,23
No previous study has investigated the
impact of dynamic exercise on IOP
regarding the β2AR gene polymorphism. As
a result, we explored whether a relationship
exists between these gene mutations and the
IOP response to acute dynamic exercise.
Materials and methods
PARTICIPANTS
Nineteen healthy male adult students (mean
age, 22.6 ± 2.8 years) volunteered to participate
in this study. Before enrolment, each underwent
a preliminary examination, including slit-
lamp, gonioscopic, ophthalmoscopic and
refractive error evaluation. No ocular
pathology was seen. The subjects also had no
history of systemic or ocular diseases and
were not using topical or systemic
medications. 
PROCEDURE
Volunteers performed exercise testing in the
form of a 20 m Shuttle Run Test (Endurance
Shuttle Run Test). They ate ≥ 2 h before the
test, ambient temperature was 21°C, no
warm-up exercises were allowed and each
participant had a 10-min rest in the supine
position before testing started at 09.00.
Testing began at walking pace, with subjects
moving between lines 20 m apart. A sound
signal dictated changes of direction and
pace, which gradually got faster: each
subject scored a successful lap when they
crossed the end line with at least one foot
when, or shortly before, the signal sounded.
Failure to reach the end line more than once
in succession before the sound indicated that
the subject could not maintain the required
pace. The individual score was then taken 
as the lap number at which the second
successive failure occurred, or as the number
of the last completed lap if a subject stopped.
The maximal oxygen uptake (VO2max) value
of each subject was estimated as an indicator
of individual cardio-respiratory endurance,
using a table prepared for this test. 
For each subject, IOPs were measured with
a Perkins hand applanation tonometer
(Clement Clarke International Ltd, Harlow,
UK) pre- and immediately post-exercise, at
10.00, 12.00 and 16.00, after instilling one
drop of benoxinate hydrochloride 0.2%, and
fluorescein sodium 0.25% in each eye. All
IOP measurements were performed by the
same person, beginning with the right eye.
Body weight (kg), height (cm), body mass
index (kg/m2), and VO2max were recorded for
each subject.
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K Güngör, H Beydağı, N Bekir et al.
Intraocular pressure: b2-adrenergic receptor polymorphism
GENOTYPING
The mutation sites of the β2AR gene were
identified by polymerase chain reaction-
restriction fragment length polymorphism
(PCR-RFLP) analysis.24 The PCR reactions
were undertaken in a total volume of 25 µl,
containing specified amounts of DNA as
template, 0.2 µmol/l of each primer 
(all primers were synthesized by TIB Molbiol,
Berlin, Germany), 0.5 U Taq-DNA poly-
merase (Gibco, New Zealand), 0.2 mmol/L 
of each dNTP (Boehringer-Mannheim,
Germany), 10 mmol/l Tris–HCl (pH 8.8), 
50 mmol/l KCl, and 1.5 mmol/l MgCl2. 
A 242 base pair (bp) fragment, including
both the polymorphic sites at codon 16 
and 27, was amplified using primers
5′-GAACGGCAGCGCCTTCTTGCTGGCACC-
CCAT (sense, AB3) and 5′-CTGCCAGG
CCCATGACCAGATCAG (anti-sense, AB2).
Compared with the natural sequence of the
β2AR, the underlined C was changed from A
to C, to generate a polymorphism-specific
restriction site. Conditions for PCR were as
follows: 2 min initial denaturation at 94 °C,
35 cycles of amplification (denaturation 
94 °C, 30 s; primer annealing 64 °C, 45 s;
polymerization 72 °C, 1 min) followed by
final elongation (7 min, 72 °C), undertaken
using a thermal cycler (9700 PCR-
thermocycler, Perkin Elmer, USA). The 
PCR products were separated into two tubes,
each containing 10 µl aliquots. To detect 
the Arg16Gly polymorphism, overnight
digestion at 37 °C with 10 U Eco130I
(Fermentas, St Leon-Rot, Germany) was
performed in one tube of the PCR product,
whereas presence of the Gln27Glu
polymorphism was identified in the second
tube using 10 U Fnu4HI (New England
BioLabs, Frankfurt, Germany). To evaluate
the mutation at codon 164, a second 
PCR procedure was performed, generating 
a 280 bp fragment with primers 
5′-GTGATCGCAGTGGA-TCGCTACT (sense,
AB4) and 5′-AGACGAAGACCATGATCACCAG
(anti-sense, AB5) under the conditions
described above, except primer annealing
was at 58 °C. Again, 10 µl of the PCR product
was digested by 10 U Mn1I (New England
BioLabs). All RFLP fragments were separated
on a 3% 3:1 NuSieve-agarose gel and
documented with a still video system (Vilber
Lourmat, Torcy, France).
STATISTICAL ANALYSIS
Statistical analyses were undertaken using
Wilcoxon matched-pair signed-rank test for
dependent groups and one-way ANOVA test
for independent groups, with P < 0.05
regarded as statistically significant. All
computations were made using SPSS
software (SPSS Inc., Illinois, USA).
Results
Results of the 20 m Shuttle Run Test showed
that all participants had good VO2max values
and were designated physically fit subjects. 
Table 1 shows the β2AR genotype
distribution among subjects according to
results of the PCR-RFLP. Polymorphisms of
TABLE 1: 
b2-adrenergic receptor genotype distribution of subjects (n = 19)
Arg16Gly Gln27Glu Thr164Ile
0 (wild type) 3 11 19 
1 (heterozygote mutant) 8 5 – 
2 (homozygote mutant) 8 3 –
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No statistical difference was found for
weight, height, body mass index or VO2max
between subjects with the Arg16Gly and
Gly16Gly (Table 2) genotypes. Subjects with
the Arg16Gly genotype demonstrated a
statistically significant reduction in IOP 
in both eyes immediately post-exercise 
(P < 0.02), although by 10.00, mean IOP
values were returning to pre-exercise levels.
Subjects with Gly16Gly also demonstrated a
statistically significant reduction (P < 0.02) in
mean IOP in both eyes after exercise, but
recovery of IOP to pre-exercise levels took 
Gln27Glu and Thr164Ile were studied, but
appropriate genotype distribution could not
be provided, therefore statistical analyses of
these polymorphisms were not performed.
Results of the PCR-RFLP identified three
subjects with Arg16Arg, eight with Arg16Gly,
and eight with Gly16Gly genotypes. Tables 
2 and 3 show physical features and IOP
pressures among subjects according to
Arg16Gly mutations. The limited number of
subjects with Arg16Arg genotype (n = 3)
meant that statistical analyses could not be
applied to this group. 
TABLE 2: 
Distribution of the Arg16Gly polymorphism and physical and metabolic characteristics of
subjects
Physical and metabolic Arg16Arg Arg16Gly Gly16Gly
characteristics n = 3 n = 8 n = 8 P-value
Height (cm) 175.33 ± 7.51 181.13 ± 4.22 180.25 ± 8.03 NS
Body weight (kg) 71.00 ± 14.73 73.00 ± 5.71 74.88 ± 8.98 NS
Mean age (years) 24.00 ± 3.61 21.88 ± 2.47 22.75 ± 3.01 NS
BMI (kg/m2) 22.91 ± 2.78 22.23 ± 1.25 22.99 ± 1.71 NS
VO2max 50.67 ± 4.80 49.89 ± 3.41 47.68 ± 2.48 NS
(ml/kg per min)
All data are mean ± SD. 
NS, not significant.
P > 0.05; one-way ANOVA test.
TABLE 3: 
Intraocular pressures recorded in subjects pre- and post-exercise, according to genotype
Intraocular pressure (mmHg)
Before 
exercise Immediately
Genotype Eyes (09.00) post-exercise 10.00 12.00 16.00
Arg16Arg Right 12.33 ± 1.53 6.00 ± 1.00 9.67 ± 0.58 10.67 ± 2.08 11.67 ± 0.58 
(n = 3) Left 11.67 ± 2.08 8.67 ± 3.06 9.00 ± 1.00 10.33 ± 2.08 11.67 ± 0.58 
Arg16Gly Right 11.75 ± 2.71 8.38 ± 1.69** 11.13 ± 2.47 12.13 ± 1.73 12.50 ± 0.76 
(n = 8) Left 11.75 ± 2.43 9.13 ± 3.04** 11.13 ± 2.10 12.63 ± 1.60 13.13 ± 0.83 
Gly16Gly Right 13.13 ± 2.03 7.63 ± 2.33** 11.25 ± 2.12** 10.38 ± 2.13* 12.88 ± 1.81
(n = 8) Left 13.63 ± 1.30 7.50 ± 2.39** 11.00 ± 1.77** 11.25 ± 2.05* 12.38 ± 2.13  
All data are mean ± SD. 
*P < 0.05; **P < 0.02 (Wilcoxon matched-pair signed-rank test).
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> 2.5 h (P < 0.05, Table 3) and there was a
greater decrease in IOP immediately post-
exercise (Table 3). 
Discussion
Compared to individuals with the Arg16Gly
genotype, our study showed that it took at
least 2.5 h for IOP to return to baseline
values in subjects with the Gly16Gly
genotype after acute dynamic exercise,
therefore an association between post-
exercise IOP levels and Gly16Gly β2AR gene
polymorphism is postulated. The β2ARs 
are membrane-bound G protein-coupled
receptors, which transmit signals after
binding of their ligands, epinephrine or
norepinephrine.
Green et al.23 found that the polymorphism
of the human β2AR gene alters agonist-
promoted down-regulation: polymorphisms
created by site-directed mutagenesis of
cloned human β2AR cDNA were expressed in
Chinese hamster fibroblasts. They also
proposed that these polymorphisms may be
responsible for inter-individual variations in
expression, regulation, and functional
properties of β2ARs.
The present study is the first to evaluate
the mechanism of post-exercise decreases in
IOP in terms of β2AR gene polymorphism
expression, which also implies that
variations exist in response to circulating
catecholamines. Endogenous catecho-
lamines may induce down-regulation
phenotypes,22 therefore receptor function
could be altered by amino-terminal receptor
polymorphism.22,25 The β2-AR gene poly-
morphism influences physical activity and
antropometric variables,26 and studies that
demonstrate how gene–exercise relations
regulate the treatment of chronic
ophthalmic disease are warranted: β2AR
polymorphism may be disease-modifying
(treatment for conditions such as
asthma,17,20,27,28 diabetes mellitus,29,30
hypertension,31 myasthenia gravis,32 conges-
tive heart disease,33 and obesity30 can be
affected).
Many reports demonstrate that exercise
lowers IOP in healthy subjects and people
with glaucoma,4,23,34 – 39 although the exact
mechanism of exercise-induced ocular
hypotension remains unclear. Several
concepts have been proposed: increases in
blood lactate levels, plasma osmolarity and
reductions in blood pH are associated with
decreasing IOP after short-term exercise in
humans and rabbits,6,8,11 although a study
comparing aerobic and anaerobic exercise
found no statistically significant IOP
decrease, despite significant differences in
blood pH and lactate levels between the
study groups.8 This paper concluded that
parameters other than decreasing blood pH
and increasing blood lactate levels are
responsible for much of the decrease in IOP
that is associated with dynamic exercise.8
The effect of continuous and increasingly
difficult periods of standardized, sub-
maximal workload on IOP were evaluated in
another paper, reporting that two opposing
mechanisms affect IOP changes during
exertion: a fall in IOP secondary to
physiological changes produced during
exercise, and a negative feedback response
causing a compensatory rise in decreased IOP.2
Acute, dynamic exercise may reduce IOP
by three possible mechanisms:11 first,
increased blood colloid osmotic pressure may
dehydrate the eye through the retinal and
uveal vascular structure; secondly, an
increase in colloid osmotic pressure may
decrease aqueous formation through
reduced ultrafiltration; thirdly, colloid
osmotic pressure may affect the
hypothalamus, with IOP changes caused by
reflex responses.11 One could hypothesize
that acute exercise may decrease IOP by
References
1 Lempert P, Cooper KH, Culver JF, Tredici TJ: The
effect of exercise on intraocular pressure. Am J
Ophthalmol 1967; 63: 1673 – 1676.
2 Shapiro A, Shoenfeld Y, Shapiro Y: The effect of
standardised submaximal workload on
intraocular pressure. Br J Ophthalmol 1978; 62:
679 – 681.
3 Passo MS, Goldberg L, Elliot DL, Van Buskirk
EM: Exercise training reduces intraocular
pressure among subjects suspected of 
having glaucoma. Arch Ophthalmol 1991; 109:
1096 – 1098.
4 Era P, Parssinen O, Kallinen M, Suominen M:
Effect of bicycle ergometer test on intraocular
pressure in elderly athletes and controls. 
Acta Ophthalmol Scand 1993; 71: 301 – 307.
5 Qureshi IA: The effects of mild, moderate, and
severe exercise on intraocular pressure in
glaucoma patients. Jpn J Physiol 1995; 45:
561 – 569. 
6 Marcus DF, Krupin T, Podos SM, Becker B: The
effect of exercise on intraocular pressure. II.
Rabbits. Invest Ophthalmol Vis Sci 1970; 9:
753 – 757.
7 Leighton DA, Philips CI: Effect of moderate
• Received for publication 20 June 2001 • Accepted 28 June 2001
©2002 Cambridge Medical Publications
31
K Güngör, H Beydağı, N Bekir et al.
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K Güngör, H Beydağı, N Bekir et al.
Intraocular pressure: b2-adrenergic receptor polymorphism
34 Shapiro A, Wolf E, Ferber I, Merin S: The effect
of physical activity in the intraocular pressure
of glaucomatous patients. Eur J Appl Physiol
1983; 52: 136 – 138.
35 Harris A, Arend O, Bohnke K, Kroepfl E, Danis
R, Martin B: Retinal blood flow during dynamic
exercise. Graefes Arch Clin Exp Ophthalmol 1996;
234: 440 – 444. 
36 Kergoat H, Forcier P: Correlation of an exercise-
induced increase in systemic circulation with
neural retinal function in humans. Doc
Ophthalmol 1996; 92: 145 – 157. 
37 Erb C, Brody S, Rau H: Effect of mental and
physical stress on intraocular pressure – a pilot
study (in German). Klin Monatsbl Augenheilkd
1998; 212: 270 – 274 
38 Movaffaghy A, Chamot SR, Petrig BL, Riva CE:
Blood flow in the human optic nerve head during
isometric exercise. Exp Eye Res 1998; 67: 561 – 568.
39 Avunduk AM, Yilmaz B, Sahin N, Kapicioglu Z,
Dayanir V: The comparison of intraocular
pressure reductions after isometric and
isokinetic exercises in normal individuals.
Ophthalmologica 1999; 213: 290 – 294.
40 Stewart RH, LeBlanc R, Becker B: Effects of
exercise on aqueous dynamics. Am J Ophthalmol
1970; 69: 245 – 248. 
41 Podos S, Minas T, Moori F: A new instrument to
measure episcleral venous pressure. Arch
Ophthalmol 1968; 80: 209 – 211.
42 Bray MS: Genomics, genes, and environmental
interaction: the role of exercise. J Appl Physiol
2000; 88: 788 – 792.
43 Liggett SB: Molecular and genetic basis of the
β2-adrenergic receptor function. J Allergy Clin
Immunol 1999; 103: S42 – S46.
Address for correspondence
Dr K Güngör
Fatih Mah, 33 Sok, No: 4 Daire 7, Sevgi Apt. Sehitkamil, Gaziantep, Turkey 27070.
E-mail: gulenkg@superonline.com
